WSG-ARA_3: WSG-ARA, figure 3

WSG-ARA_3R Documentation

WSG-ARA, figure 3

Description

Kaplan-Meier digitized data from WSG-ARA, figure 3 (PMID 24356620). A reported sample size of 1,234 for a primary endpoint of EFS in breast cancer.

Usage

`WSG-ARA_3`

Format

A data frame of 1,170 observations and 3 variables:

time event time (in months)
event EFS event indicator (0: no event, 1: event)
arm treatment arms (da_negative, da_positive)

Source

Nitz U, Gluz O, Zuna I, et al. Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer. Ann Oncol 2014; 25: 75–80.

Examples

summary(`WSG-ARA_3`)

kmplot(`WSG-ARA_3`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.